Sapablursen

DB18608InvestigationalGene Therapies

Sapablursen is a synthetic 2'-O-(2-methoxyethyl)-modified antisense oligonucleotide linked to a tri-antennary cluster of N-acetyl galactosamine (GalNAc3) sugars targeting transmembrane protease, serine 6 messenger ribonucleic acid.

Code names
IONIS TMPRSS6-LRx · ISIS-702843

Resolves to

What you can answer from here — as of May 26, 2026

4Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Sapablursen, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account